---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-288703"
form_type: "8-K"
ticker: "LXEO"
cik: "0001907108"
company_name: "Lexeo Therapeutics, Inc."
filed_at: "2026-06-29T21:06:22+00:00"
generated_at: "2026-06-29T21:08:27.506126+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lexeo Therapeutics reports 2026 annual meeting results; all director nominees elected

## Summary
- Elected Class III directors Townsend (64.7M FOR), Cooperstone (48.8M FOR), and Cholmondeley (64.7M FOR); broker non-votes ~10M each.
- Ratified KPMG as independent auditor for fiscal 2026: 75.5M FOR, 55.6K AGAINST, 30.1K abstain.
- Annual Meeting held virtually on June 25, 2026.

## SEC filing metadata
- accession: 0001193125-26-288703
- form_type: 8-K
- ticker: LXEO
- cik: 0001907108
- company_name: Lexeo Therapeutics, Inc.
- filed_at: 2026-06-29T21:06:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/0001193125-26-288703-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907108/000119312526288703/lxeo-20260625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-288703
- JSON: https://secwatch.observer/filing/0001193125-26-288703.json
- Plain text: https://secwatch.observer/filing/0001193125-26-288703.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.